In today's rapidly evolving business landscape, access to accurate and actionable market intelligence is critical for maintaining competitive advantage. MarketsandMarkets has established itself as a global leader in strategic market ....see more
The healthcare digital signage market is expected to grow from USD 0.75 billion in 2025 to USD 1.10 billion by 2030, at a CAGR of 8.0% during the forecast period. Leading players in the Healthcare Digital Signage Market include Samsung Electronics Co., Ltd. (South Korea), LG Electronics (South Korea), Sharp NEC Display Solutions (Japan), Barco (Belgium), STRATACACHE including Scala (US), BrightSign LLC (US), Omnivex Corporation (Canada), Broadsign (Canada), Visix, Inc. (US), Daktronics (US), and others.
The Europe pharmaceutical drug delivery market was estimated to be worth USD 519.6 million in 2026 and is poised to reach USD 703.2 million by 2031, growing at a CAGR of 6.2% from 2025 to 2031. The Key Players Johnson & Johnson Services,Inc. (US), Pfizer Inc. (US), Fresenius Kabi (Germany), Becton, Dickinson and Company (US), Nemera (France), B. Braun (Germany), Gerresheimer AG (Germany), SHL Medical (Switzerland), Novo Nordisk (Denmark), Novartis (Switzerland), Sanofi (France), Baxter International (US), AstraZeneca (United Kingdom), Roche (Switzerland), and medmix (Switzerland).
US Indoor Location Market
The Pharmaceutical Manufacturing Execution System market is expected to grow from USD 2.37 billion in 2025 to USD 4.62 billion by 2030, at a compound annual growth rate (CAGR) of 14.3 during the forecast period. The Key Players Siemens (Germany, Dassault Systèmes (France), SAP SE (Germany), ABB (Switzerland), Rockwell Automation (US), Honeywell International Inc. (US), Emerson Electric Co. (US), Yokogawa Electric (Japan), Schneider Electric (France).
The asia pacific anti-counterfeit packaging market is expected to grow from USD 51.2 billion in 2025 to USD 105.4 billion by 2030, at a CAGR of 15.45% during the forecast period. The Asia Pacific anti-counterfeit packaging market comprises major players such as Holostik (India), UFlex (India), SML Group Ltd. (Hong Kong SAR, China), Holoflex (India), and Toppan Inc. (Japan). Partnerships, acquisitions, and product launches are among the key strategies adopted by these major players to strengthen their positions in the anti-counterfeit packaging market.
The HVAC services market is projected to reach USD 97.9 billion by 2030 from USD 72.5 billion in 2025, at a CAGR of 6.2% from 2025 to 2030.
The asia pacific polymer foam market is expected to grow from USD 44.03 billion in 2024 to USD 63.93 billion by 2030, at a CAGR of 6.4% during the forecast period. Sheela Foam Limited (India), Dura Foam Industries Pvt. Ltd. (India), Duroflex Foam (India), Toray Industries, Inc. (Japan), and King Koil India (India) are the leading players in the market. There is significant competition in the polymer foam market to develop new process technology, lower the manufacturing cost, and increase the use of polymer foam in end-use industries.
The aviation fuel market is expected to grow from USD 203.66 billion in 2025 to USD 329.03 billion by 2031, at a compound annual growth rate (CAGR) of 8.3%. during the forecast period. The Key Players Exxon Mobil Corporation (US), Chevron Corporation (US), BP plc (UK), Shell (UK), and TotalEnergies (France).
The global dental laboratories market, valued at US$8.66 billion in 2024, stood at US$9.20 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$13.09 billion by the end of the period. Advancements in dental technologies—including CAD/CAM systems, 3D printing, intraoral scanning, and high-performance restorative materials—are enabling greater precision, faster turnaround times, and improved aesthetic outcomes compared to traditional manual techniques.
The global in vitro diagnostics market, valued at US$37.43 billion in 2025, stood at US$40.15 billion in 2026 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2031, culminating in a forecasted valuation of US$57.18 billion by the end of the period. This growth is primarily driven by the rising prevalence of chronic and infectious diseases, the increasing demand for early and accurate diagnostic testing, the widespread adoption of advanced molecular diagnostic technologies, the growth in point-of-care testing, and continuous innovations in diagnostic instruments and assays.
The global hybrid bonding market is expected to grow from USD 164.7 million in 2025 to USD 633.9 million by 2032, at a compound annual growth rate (CAGR) of 21.2% during the forecast period. The Key Players EV Group (EVG) (Austria), Applied Materials, Inc. (US), SUSS MicroTec SE (Germany), Besi (Netherlands), Kulicke & Soffa Industries, Inc. (Singapore), Tokyo Electron (TEL) (Japan), and ASMPT (Singapore).
The polyhydroxyalkanoate (PHA) market is expected to grow from USD 123.8 million in 2025 to USD 265.2 million by 2030, at a CAGR of 16.5% during the forecast period. The key players profiled in the report include Teknor Apex (US), Kaneka Corporation (Japan), Ecomann Biotechnology Co., Ltd. (China), RWDC Industries (Singapore), Bluepha Co., Ltd. (China), Newlight Technologies, Inc. (US), Ningbo Tianan Biologic Materials Co., Ltd. (China), Biomer (Germany), Beijing PhaBuilder Biotechnology Co., Ltd. (China), and TerraVerdae Bioworks Inc. (Canada).
The nutraceutical excipients market is expected to grow from USD 4.98 billion in 2025 to USD 7.12 billion by 2030, at a CAGR of 7.4% during the forecast period. The report profiles key players such as International Flavors & Fragrances Inc. (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc. (US), SEPPIC (US), Azelis Group (Luxembourg), and Biogrund GmbH (Germany).
The gas sensor market is expected to grow from USD 1.78 billion in 2025 to USD 3.20 billion by 2033, at a compound annual growth rate (CAGR) of 7.6% during the forecast period.The key players Honeywell International Inc. (US), MSA Safety Incorporated (US), Amphenol Corporation (US), Figaro Engineering Inc. (Japan), Alphasense (UK), Sensirion AG (Switzerland), Process Sensing Technologies (UK), ams-OSRAM AG (Austria), MEMBRAPOR (Switzerland), and Senseair AB (US).
The global cell therapy technologies market, valued at US$4.05 billion in 2024, stood at US$4.41 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$7.91 billion by the end of the period.